Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.


Journal Article

Full Text

Duke Authors

Cited Authors

  • Shankar, LK; Hoffman, JM; Bacharach, S; Graham, MM; Karp, J; Lammertsma, AA; Larson, S; Mankoff, DA; Siegel, BA; Van den Abbeele, A; Yap, J; Sullivan, D; National Cancer Institute,

Published Date

  • June 2006

Published In

Volume / Issue

  • 47 / 6

Start / End Page

  • 1059 - 1066

PubMed ID

  • 16741317

Pubmed Central ID

  • 16741317

International Standard Serial Number (ISSN)

  • 0161-5505


  • eng

Conference Location

  • United States